European Journal of Radiology
Volume 54, Issue 3 , Pages 418-425 , June 2005

The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma

  • Ayman A. Sakr

      Affiliations

    • Department of Radiation Sciences, Radiology Unit, Medical Research Institute, University of Alexandria, 165 Horreya Avenue, El Hadara, Alexandria, Egypt
    • Corresponding Author InformationCorresponding author. Present Address: Department of Radiology, Almana General Hospital, P.O.Box 10366, Jubail 31961, Saudi Arabia. Tel.: +966 3 341 2000x1048 (Work +966 3 347 1377 Mobile +20 12 397 4123); fax: +966 3 341 7794.
  • ,
  • Alaa Ahmed Saleh

      Affiliations

    • Department of Radiation Sciences, Radiology Unit, Medical Research Institute, University of Alexandria, 165 Horreya Avenue, El Hadara, Alexandria, Egypt
  • ,
  • Amr Ali Abdel Moeaty

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
  • ,
  • Ali Abdel Moeaty

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt

Received 4 December 2003 ,Revised 18 June 2004 ,Accepted 25 June 2004.

References 

  1. Caturelli E, Siena DA, Fusilli S, et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to non-tumorous liver tissue—long-term prospective study. Radiology. 2000;215:123–128
  2. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992;15:948–955
  3. Adachi M, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995;108:768–775
  4. Goldberg SN, Charboneau JW, Dodd GD, et al. For the international working group on image-guided tumor ablation image-guided tumor ablation. proposal for standardization of terms and reporting criteria. Radiology. 2003;228:335–345
  5. Rhim H, Nahum Goldberg S, Dodd GD, et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21:517–539
  6. Livraghi T, Nahum Goldberg S, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology. 2000;214:761–768
  7. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology. 2000;217:633–646
  8. Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors using percutaneous RF therapy. Am. J. Roentgenol. 1988;170:1023–1028
  9. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer. 1991;69:925–929
  10. Livraghi T, Lazzaroni S, Pellicano S, Ravasi S, Torzilli G, Vettori C. Percutaneous ethanol injection of hepatic tumors: Single session therapy with general anesthesia. Am. J. Roentgenol. 1993;161:1065–1069
  11. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995;197:101–108
  12. Kurokohchi K, Watanabe S, Masaki T, et al. Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocellular carcinoma. Int. J. Oncol. 2002;21:841–846
  13. Pacella CM, Bizzarri G, Cecconi P, et al. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter. Arterial chemoembolization. Radiology. 2001;219:669–678
  14. Qian J, Feng G-S, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J. Gastroenterol. 2003;9(9):1885–1891
  15. Bloomston M, Binitie O, Fraiji E, et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am. Surg. 2002;68:827–831
  16. Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer. 2001;92:1516–1524
  17. Lencioni R, Paolicchi A, Moretti M, et al. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Eur. Radiol. 1998;8:439–444
  18. Kirchhoff T, Chavan A, Galanski M. Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 1998;10:907–909
  19. Lencioni R, Cioni D, Donati F, Bartolozzi C. Combination of interventional therapies in hepatocellular carcinoma. Hepatogastroenterology. 2001;48:8–14
  20. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology. 2001;221:447–454
  21. Bartolozzi C, Lencioni R, Caramella D, Falaschi F, Cioni R, DiCoscio G. Hepatocellular carcinoma. CT and MR features after transcatheter arterial emobilization and percutaneous ethanol injection. Radiology. 1994;191:123–128
  22. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am. J. Roentgenol. 1996;167:759–768
  23. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumor by an expandable RFA needle electrode. Am. J. Roentgenol. 1998;170:1015–1022
  24. Shiina S, Niwa Y. Percutaneous ethanol injection therapy in the treatment of liver neoplasm. In:  Cope C editors. Current Techniques in Interventional Radiology. Philadelphia, PA: Current Medicine; 1994;p. 31–314
  25. Solbiati L, Livraghi T, Goldberg SN, Ierace T, DellaNoce M, Gazelle GS. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–166
  26. Kurokohchi K, Watanabe S, Masaki T, et al. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat. Int. J. Oncol. 2002;21:611–615
  27. Liovet JM, Real MI, Montana X, et al. Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in, patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734–1739
  28. Fan J, Ten GJ, He SC, Guo JH, Yang DP, Wang GY. Arterial chemoembolization for hepatocellular carcinoma. World J. Gastroenterol. 1998;4:33–37
  29. Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:319–328
  30. Kamada K, Kitamoto M, Aikata H, et al. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am. J. Surg. 2002;184:284–290
  31. Kettenbach J, Kostler W, Rucklinger E, et al. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. Am. J. Roentgenol. 2003;180(6):1537–1545
  32. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology. 1999;210:655–661

PII: S0720-048X(04)00229-3

doi: 10.1016/j.ejrad.2004.06.008

European Journal of Radiology
Volume 54, Issue 3 , Pages 418-425 , June 2005